Regenerex Pharma (RGPX) Shares Outstanding (Weighted Average) (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $281.4 million in Q3 2025.

• Shares Outstanding (Weighted Average) for Q3 2025 came in at $281.4 million, up 9569.65% year-over-year; the trailing twelve-month figure through Sep 2025 was $281.4 million (up 9569.65% YoY), and the FY2025 annual result was $278.7 million, up 10586.39% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $281.4 million in Q3 2025 per RGPX's latest filing, from $281.1 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $281.4 million in Q3 2025 and troughed at $1.1 million in Q2 2023.
• A 5-year average of $180.0 million and a median of $240.4 million in 2021 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) sank 99.17% in 2023, then jumped 24853.03% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $203.7 million in 2021, then jumped by 36.01% to $277.1 million in 2022, then plunged by 99.12% to $2.4 million in 2023, then surged by 11347.68% to $278.4 million in 2024, then gained by 1.07% to $281.4 million in 2025.
• Business Quant data shows RGPX's Shares Outstanding (Weighted Average) at $281.4 million in Q3 2025, $281.1 million in Q2 2025, and $278.7 million in Q1 2025.